← Eichor
Study identifier: NCT05684510 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Treatment of Mild Class II Malocclusion in Adult Patients With Clear Aligners Versus Fixed Multibracket Therapy

Condition: Malocclusion · Class II Malocclusion  ·  Sponsor: Hama University

PhaseNA
Planned participants24
Who can joinAll sexes, 15 Years to 20 Years
Healthy volunteersNo

About this study

Patient with class ii division 1 malocclusion who have mild increased overjet will be treated in this study. The efficacy of clear aligners in the treatment of Class II division 1 Malocclusion Using Intermaxillary Elastics will be assessed. The skeletal, dental and soft tissues changes resulted by this intervention will be studied and compared with the results of Traditional treatment with fixed appliances. There are two group: 1. a group of patients in which participants will be undergo to the clear aligners with class ii elastics. 2. a group of patients in which participants will be undergo to the traditional fixed appliances with class ii elastics.

This description comes directly from the study's public registry record.

Talk to the study team

Fadi Jnaid  ·  988499015  ·  Drfadijnaid@gmail.com

FATIMA NASHTR, MSc  ·  fatimahnashtar96@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Hama UniversityHama, Hama Governorate, SyriaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05684510